(Q41157505)

27 September 2017

1 reference

title

Liver transplantation in virus-induced chronic liver disease (English)

1 reference

27 September 2017

chronic liver disease

0 references

author name string

A Colantoni

1

1 reference

27 September 2017

N De Maria

2

1 reference

27 September 2017

S Fagiuoli

3

1 reference

27 September 2017

D H Van Thiel

4

1 reference

27 September 2017

1 July 1996

1 reference

Bailliere's clinical gastroenterology

27 September 2017

1 reference

27 September 2017

10

1 reference

27 September 2017

375-388

1 reference

27 September 2017

2

1 reference

Quantitation of hepatitis C virus RNA in liver transplant recipients

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Retransplantation in hepatitis B--a multicenter experience

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Recurrence of hepatitis D (delta) in liver transplants: histopathological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Types, causes, and therapies of hepatitis occurring in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Reinfection of liver graft by hepatitis C virus after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Hepatitis C viral infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Liver transplantation for hepatitis B: what have we learned and what does the future hold?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Ribavirin therapy for hepatitis C infection following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

The use of granulocyte-macrophage colony-stimulating factor to enhance hematologic parameters of patients with cirrhosis and hypersplenism.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Should liver transplantation be performed for patients with chronic hepatitis B? Yes!

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Significance of extrahepatic replication of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Patterns of hepatitis delta virus reinfection and disease in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Diagnosis of chronic hepatitis C after liver transplantation by the detection of viral sequences with polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Incidence, prevalence, and clinical course of hepatitis C following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3528%2896%2990011-1

7 January 2021

10.1016/S0950-3528(96)90011-1

Identifiers

DOI

1 reference

27 September 2017

1 reference